- KSNM 60 years: International Collaboration with Asian Nuclear Medicine Community
-
Hatazawa J
- KMID: 2516687
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):105-106.
- doi: 10.1007/s13139-021-00692-9
-
- CITED
-
- Close
- SHARE
-
- Close
- The Outcome and Safety of Re-challenge Lutetium-177 PSMA (177Lu-PSMA) Therapy with Low-Dose Docetaxel as a Radiosensitizer—a Promising Combination in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): a Case Report
-
Maharaj M, Heslop L, Govender T, Korowlay N, Singh A, Choudhary P, Sathekge M
- KMID: 2516692
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):136-140.
- doi: 10.1007/s13139-021-00696-5
Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (PSMA-RLT) with lutetium-177 ( 177Lu-PSMA) has been used in metastatic castrate-resistant prostate cancer (mCRPC), and retrospective data have shown this therapy to be favourably... -
- CITED
-
- Close
- SHARE
-
- Close
- Rosai-Dorfman Disease: Importance of 18F FDG PET/CT to Determine Extension and Extranodal Involvement
-
Murad V, Cheon GJ
- KMID: 2516694
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):146-148.
- doi: 10.1007/s13139-021-00683-w
Rosai-Dorfman disease or sinus histiocytosis with lymphadenopathy is a rare benign histiocytic proliferative disorder of unknown etiology first described in 1969. It typically affects older females and most common presentation... -
- CITED
-
- Close
- SHARE
-
- Close
- Angiogenesis-Targeted 68Ga-DOTA-RGD 2 PET/CT Imaging: a Potential Theranostic Application in the Case of Chondrosarcoma
-
Krishnaraju VS, Kumar R, Sood A, Shukla J, Subramanian K, Kakkar N, Panda N, Mittal BR
- KMID: 2516693
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):141-145.
- doi: 10.1007/s13139-021-00691-w
Chondrosarcoma is a cartilaginous tumor of mesenchymal origin. The histology and grade of the tumor determine the chances of relapse and survival. These tumors usually respond poorly to chemo-radiotherapy in... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantification of Hypoxia in Human Glioblastoma using PET with 18F-FMISO
-
Abdo Ra, Lamare F, Fernandez P, Bentourkia M
- KMID: 2516688
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):107-115.
- doi: 10.1007/s13139-021-00693-8
Purpose: This study aimed to investigate the results of compartmental modeling (CM) and spectral analysis (SA) generated with dynamic 18F-FMISO tumor images. Besides, the regular tissue-to-blood ratio (TBR) images were... -
- CITED
-
- Close
- SHARE
-
- Close
- Change of Therapeutic Response Classification According to Recombinant Human Thyrotropin‑Stimulated Thyroglobulin Measured at Different Time Points in Papillary Thyroid Carcinoma
-
Moon J, Jeon S, Park K, Yoo S, Kang S, Cho S, Kim J, Lee C, Song H, Min J, Bom H, Kwon S
- KMID: 2516689
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):116-122.
- doi: 10.1007/s13139-021-00699-2
Purpose: We investigated whether response classification after total thyroidectomy and radioactive iodine (RAI) therapy could be affected by serum levels of recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin (Tg) measured at different... -
- CITED
-
- Close
- SHARE
-
- Close
- One Versus Up‑to‑5 Lesion Measurements for Response Assessment by PERCIST in Patients with Lung Cancer
-
Kwon S, O JH, Yoo I
- KMID: 2516690
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):123-129.
- doi: 10.1007/s13139-021-00697-4
Purpose: The optimal number of lesions to measure for response assessment from fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) is not validated for lung cancer. We compared 1... -
- CITED
-
- Close
- SHARE
-
- Close
- Extended Whole‑body Ga‑68 DOTATATE PET‑CT in evaluating Tumour‑Induced Osteomalacia: Case report and review of literature
-
Tan T, Chen E, Chew M, Chye P, Wong M
- KMID: 2516691
- Nucl Med Mol Imaging.
- 2021 Jun;55(3):130-135.
- doi: 10.1007/s13139-021-00695-6
Tumour-induced osteomalacia is a rare paraneoplastic syndrome that manifests as chronic hypophosphataemia, non-specific bone pain and muscle weakness. It is generally caused by phosphaturic mesenchymal tumour (PMT), which is uncommonly... -
- CITED
-
- Close
- SHARE
-
- Close
